RxDoctor Payments Data

Jacqueline Rohl, MD

Obstetrics & Gynecology · Columbus, OHNPI 1164510533

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 22.8% of the total. Reporting peaked in 2024 at $269 and has fallen 77.0% since, to $62 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in OH, where the typical reported total is $509.

$554in general payments, 2019–2025

Across 9 payments — averaging $61.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$126
  • Astellas Pharma US Inc$125
  • Smith+Nephew$124
  • Coopersurgical, Inc.$97
  • Gynesonics, Inc.$59
  • Medical Device Business Services, Inc.$21
$63,435in research payments, 2019–2025

Across 45 payments — averaging $1409.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$63K

What the payments were for

  • Food & beverage$554100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$554 in reported general payments places this provider in the 50th percentile of 1,376 obstetrics & gynecology providers in Ohio.

See all obstetrics & gynecology providers in Ohio

Medicare billing

Part B allowed, 2024
$5,572
Medicare patients
21
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Medroxyprogesterone Acetate19$236

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →